Nephros (NEPH) Asset Writedowns and Impairment (2015 - 2026)
Nephros (NEPH) posted Asset Writedowns and Impairment of $11000.0 for Q2 2026, little changed on a QoQ basis from $11000.0 in Q1 2026, and down 68.57% year-over-year from $35000.0 in Q2 2025.
Powered by 
Analysis
Nephros (NEPH) Asset Writedowns and Impairment (2015 - 2026) Analysis & Trends
Nephros has reported Asset Writedowns and Impairment for 12 years, with the latest figure at $11000.0 in Q2 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 68.57% year-over-year to $11000.0 in Q2 2026; TTM through Jun 2026 was $49000.0, a 60.16% decrease from a year earlier, with the FY2025 full-year figure at $68000.0, down 74.05% from the prior year.
- Asset Writedowns and Impairment was $11000.0 for Q2 2026 at Nephros, roughly flat from $11000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $1.3 million in Q3 2022, with the low at $6000.0 in Q1 2025.
- Average Asset Writedowns and Impairment over 5 years is $127625.0, with a median of $41500.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment soared 1396.51% in 2022, then plunged 91.78% in 2025.
- Over 5 years, Asset Writedowns and Impairment stood at $1.3 million in 2022, then sank by 85.31% to $189000.0 in 2023, then slumped by 74.6% to $48000.0 in 2024, then slumped by 75.0% to $12000.0 in 2025, then decreased by 8.33% to $11000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $11000.0 (Q2 2026), $11000.0 (Q1 2026), and $12000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 15,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 48,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 107,000.00 |
| Mar 31, 2024 | 73,000.00 |
| Dec 31, 2023 | 189,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 91,000.00 |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 59,000.00 |
| Mar 31, 2022 | 49,000.00 |
| Dec 31, 2021 | 90,000.00 |
| Sep 30, 2021 | 86,000.00 |
| Jun 30, 2021 | 28,000.00 |
| Mar 31, 2021 | 9,000.00 |